Cover Image
市場調查報告書

移植的全球市場

Global Transplantation Market 2015-2019

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 324725
出版日期 內容資訊 英文 112 Pages
訂單完成後即時交付
價格
Back to Top
移植的全球市場 Global Transplantation Market 2015-2019
出版日期: 2015年02月18日 內容資訊: 英文 112 Pages
簡介

所謂移植是將患疾病或受傷的細胞、組織、內臟器官替換成健康的,將人體修復為正常狀態的治療。腎臟、肝臟、心臟、肺、腸、胰臟、胸腺等內臟器官成為移植對象。部分組織 (角膜、骨、肌腱、心臟瓣膜、皮膚、神經、靜脈) 也可以專用的替代組織交換。腎臟移植是全球最常進行的移植手術,其次是肝臟移植、心臟移植。還有治療數量中,角膜、肌肉骨骼移植片的移植為最多。另一方面,移植手術時候,也需要移植組織產品和免疫抑制劑、組織保存液等。全球移植市場,預計2014∼2019年以9.36%的年複合成長率成長。

本報告提供全球的內臟器官等的移植市場相關分析、技術概要和市場結構、市場規模趨勢 (今後5年的預測值)、各產品種類、各地區的詳細趨勢、推動、阻礙市場要素與其影響力、主要企業簡介、今後的市場機會等調查、考察。

第1章 摘要整理

第2章 簡稱集

第3章 分析範圍

  • 市場概要
  • 主要的產品與服務

第4章 市場分析技術

  • 市場分析的流程
  • 分析方法

第5章 簡介

第6章 概要

  • 南北美洲各國所實施的器官移植數量
  • 歐洲各國所實施的器官移植數量
  • 亞太地區實施的器官移植數量

第7章 市場環境

  • 市場概況
  • 市場規模與其預測
  • 波特的五力分析

第8章 各用途的市場區隔

第9章 各產品種類的市場區隔

  • 移植用組織產品市場
  • 免疫抑制劑市場
  • 組織型判斷技術、內臟器官保存液市場
  • 替代的技術市場

第10章 地區區分

  • 南北美洲市場
  • 歐洲、中東、非洲地區 (EMEA) 市場
  • 亞太地區市場

第11章 主要國家市場

  • 美國
  • 英國
  • 法國

第12章 購買標準

第13章 促進市場成長的要素

第14章 推動因素與其影響力

第15章 市場課題

第16章 推動因素、課題的影響力

第17章 市場趨勢

第18章 市場趨勢與其影響

第19章 供應商環境

  • 競爭方案
    • 近幾年的主要趨勢
    • 企業合併、收購 (M&A)
  • 供應商分析
  • 其他的著名的供應商

第20章 主要供應商分析

  • Abbott Laboratories
    • 主要資料
    • 產業概要
    • 產業區分
    • 產業策略
    • 各部門的市場收益額 (最新值)
    • 市場收益額比較 (對上年度)
    • 各地區的市場收益額
    • 主要資訊
    • SWOT分析
  • Arthrex
  • Biomet
  • Kinetic Concepts
  • Medtronic
  • Novartis
  • Stryker

第21章 相關報告

圖表一覽

目錄
Product Code: IRTNTR5301

About Transplantation

Transplantation is the procedure in which diseased or injured cells, tissues, or organs are replaced with healthy cells, tissues, or organs to restore the normal functions of the body. Organs such as kidneys, liver, heart, lungs, intestine, pancreas, and thymus can be transplanted. Some tissues such as cornea, bones, tendons, heart valves, skin, nerves, and veins can also be replaced with specific alternative tissues. Kidney transplantation is the most common transplantation procedure worldwide, followed by liver and heart transplantations. Cornea and musculoskeletal grafts transplantations are the most common tissue transplantation procedures. The following are the products required during a transplantation procedure: transplantation tissue products, immunosuppressant drugs, and organ preservation solutions.

TechNavio's analysts forecast the Global Transplantation market to grow at a CAGR of 9.36 percent over the period 2014-2019.

Covered in this Report

This report covers the present scenario and the growth prospects of Global Transplantation market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of transplantation tissue products, immunosuppressant drugs, and organ preservation solutions. These products are used for many transplantation procedures including

  • Kidney transplantation
  • Liver transplantation
  • Heart transplantation
  • Lung transplantation
  • Pancreas transplantation
  • Other transplantation

TechNavio's report, the Global Transplantation Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the APAC and EMEA regions; it also covers the Global Transplantation market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Regions

  • Americas
  • APAC
  • EMEA

Key Vendors

  • Abbott Laboratories
  • Arthrex
  • Biomet
  • Kinetic Concepts
  • Medtronic
  • Novartis
  • Stryker

Other Prominent Vendors

  • 21st Century Medicine
  • Aastrom Biosciences
  • Accord Healthcare
  • Acologix
  • Actavis
  • Advanced Cell Technology
  • Allosource
  • Arteriocyte
  • Astellas Pharma
  • Athersys
  • Avita Medical
  • Bacterin International
  • Baxter
  • Bellicum Pharmaceuticals
  • Bioactive Regenerative Therapeutics
  • BioCardia
  • BioLife Solutions
  • Bio-Rad Laboratories
  • BioTime
  • Bridge to Life
  • Bristol-Myers Squibb
  • Cell & Tissue Systems
  • Claris Lifesciences
  • CONMED
  • Cryolife
  • Cynata Therapeutics
  • Cytomedix
  • Cytori Therapeutics
  • Dr. F. Kohler Chemie
  • Edwards Lifesciences
  • Exactech
  • Forticell Bioscience
  • GE Healthcare
  • Genzyme
  • Geron
  • GlaxoSmithKline
  • Harvard Apparatus Regenerative Technologies
  • HeartWare
  • Histogenics
  • Humacyte
  • F. Hoffmann-La Roche
  • Integra Lifescience
  • InVivo Therapeutics
  • Johnson & Johnson
  • Kensey Nash
  • Kiadis Pharma
  • Lifeblood Medical
  • Lifeline Scientific
  • Living Cell Technologies
  • Luminex
  • MaxCyte
  • Mesoblast
  • Nanofiber Solutions CTO
  • NeoStem
  • Neuralstem
  • On-X Life Technologies
  • Opexa Therapeutics
  • Organ Recovery Systems
  • Organogenesis
  • Osiris Therapeutics
  • Osteotech
  • Pfizer
  • Pluristem Therapeutics
  • Preservation Solutions
  • Quest Diagnostics
  • ReNeuron
  • RTI Surgical
  • SanBio
  • Smith & Nephew
  • St. Jude Medical
  • StemCells
  • Syncardia Systems
  • Tengion
  • Terumo Medical
  • Teva Pharmaceuticals
  • Thermo Fischer Scientific
  • Thoratec
  • Tissue Genesis
  • ToleroTech
  • TransMedics
  • Veloxis Pharmaceuticals
  • ViaCyte
  • Xvivo Perfusion
  • Zimmer

Market Driver

  • Increased Incidence of Organ Failure
  • For a full, detailed list, view our report

Market Challenge

  • Transplant Rejection
  • For a full, detailed list, view our report

Market Trend

  • Increased Government and NGO Initiatives
  • For a full, detailed list, view our report

Key Questions Answered in this Report

  • What will the market size be in 2019 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Table of Contents

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

  • 03.1. Market Overview
  • 03.2. Product Offerings

04. Market Research Methodology

  • 04.1. Market Research Process
  • 04.2. Research Methodology

05. Introduction

06. Overview

  • 06.1. Organ Transplants Performed in Americas
  • 06.2. Organ Transplants Performed in Europe Region
  • 06.3. Organ Transplants Performed in APAC Region

07. Market Landscape

  • 07.1. Market Overview
  • 07.2. Market Size and Forecast
  • 07.3. Five Forces Analysis

08. Market Segmentation by Application

09. Market Segmentation by Product Type

  • 09.1. Global Transplantation Tissue Products Market
    • 09.1.1. Market Size and Forecast
  • 09.2. Global Immunosuppressant Drugs Market
    • 09.2.1. Market Size and Forecast
  • 09.3. Global Tissue Typing Technologies and Organ Preservation Solutions Market
    • 09.3.1. Market Size and Forecast
  • 09.4. Global Alternative Technologies Market
    • 09.4.1. Market Size and Forecast

10. Geographical Segmentation

  • 10.1. Transplantation Market in Americas
    • 10.1.1. Market Size and Forecast
  • 10.2. Transplantation Market in EMEA Region
    • 10.2.1. Market Size and Forecast
  • 10.3. Transplantation Market in APAC Region
    • 10.3.1. Market Size and Forecast

11. Key Leading Countries

  • 11.1. US
  • 11.2. UK
  • 11.3. France

12. Buying Criteria

13. Market Growth Drivers

14. Drivers and their Impact

15. Market Challenges

16. Impact of Drivers and Challenges

17. Market Trends

18. Trends and their Impact

19. Vendor Landscape

  • 19.1. Competitive Scenario
    • 19.1.1. Key News
    • 19.1.2. Mergers and Acquisitions
  • 19.2. Vendor Analysis 2014
  • 19.3. Other Prominent Vendors

20. Key Vendor Analysis

  • 20.1. Abbott Laboratories
    • 20.1.1. Key Facts
    • 20.1.2. Business Description
    • 20.1.3. Business Segmentation
    • 20.1.4. Business Strategy
    • 20.1.5. Revenue by Business Segmentation
    • 20.1.6. Revenue Comparison 2011 and 2012
    • 20.1.7. Revenue by Geographical Segmentation
    • 20.1.8. Key Information
    • 20.1.9. SWOT Analysis
  • 20.2. Arthrex
    • 20.2.1. Key Facts
    • 20.2.2. Business Overview
    • 20.2.3. Product Groups
    • 20.2.4. Key Locations
    • 20.2.5. Recent Developments
    • 20.2.6. SWOT Analysis
  • 20.3. Biomet
    • 20.3.1. Key Facts
    • 20.3.2. Business Overview
    • 20.3.3. Product Segmentation by Revenue 2014
    • 20.3.4. Product Segmentation by Revenue 2013 and 2014
    • 20.3.5. Geographical Segmentation by Revenue 2014
    • 20.3.6. Business Strategy
    • 20.3.7. Recent Developments
    • 20.3.8. SWOT Analysis
  • 20.4. Kinetic Concepts
    • 20.4.1. Key Facts
    • 20.4.2. Business Overview
    • 20.4.3. Business Segmentation
    • 20.4.4. Business Segmentation by Revenue 2013
    • 20.4.5. Sales by Geography
    • 20.4.6. Business Strategy
    • 20.4.7. Recent Developments
    • 20.4.8. SWOT Analysis
  • 20.5. Medtronic
    • 20.5.1. Key Facts
    • 20.5.2. Business Overview
    • 20.5.3. Business Segmentation by Revenue 2013
    • 20.5.4. Business Segmentation by Revenue 2012 and 2013
    • 20.5.5. Geographical Segmentation by Revenue 2013
    • 20.5.6. Business Strategy
    • 20.5.7. Recent Developments
    • 20.5.8. SWOT Analysis
  • 20.6. Novartis
    • 20.6.1. Key Facts
    • 20.6.2. Business Description
    • 20.6.3. Business Segmentation
    • 20.6.4. Revenue by Business Segmentation
    • 20.6.5. Revenue Comparison 2012 and 2013
    • 20.6.6. Sales by Geography
    • 20.6.7. Business Strategy
    • 20.6.8. Key Developments
    • 20.6.9. SWOT Analysis
  • 20.7. Stryker
    • 20.7.1. Key Facts
    • 20.7.2. Business Overview
    • 20.7.3. Business Segmentation by Revenue 2013
    • 20.7.4. Business Segmentation by Revenue 2012 and 2013
    • 20.7.5. Geographical Segmentation by Revenue 2013
    • 20.7.6. Business Strategy
    • 20.7.7. Recent Developments
    • 20.7.8. SWOT Analysis

21. Other Reports in this Series

List of Exhibits

  • Exhibit 1: Market Research Methodology
  • Exhibit 2: Transplant Procedures Performed Americas 2013
  • Exhibit 3: Transplant Procedures Performed Europe Region 2013
  • Exhibit 4: Transplant Procedures Performed APAC Region 2013
  • Exhibit 5: Global Transplantation Market 2014-2019 (US$ billion)
  • Exhibit 6: Segmentation of Global Transplantation Market by Application
  • Exhibit 7: Segmentation of Global Transplantation Market by Application 2014
  • Exhibit 8: Segmentation of Global Transplantation Market by Product Type
  • Exhibit 9: Segmentation of Global Transplantation Market by Product Type 2014 and 2019
  • Exhibit 10: Global Transplantation Tissue Products Market 2014-2019 (US$ billion)
  • Exhibit 11: Global Immunosuppressant Drugs Market 2014-2019 (US$ billion)
  • Exhibit 12: Global Tissue Typing Technologies and Organ Preservation Solutions Market 2014-2019 (US$ billion)
  • Exhibit 13: Global Alternative Technologies Market 2014-2019 (US$ billion)
  • Exhibit 14: Segmentation of Global Transplantation Market by Product Type 2014-2019 (in billion)
  • Exhibit 15: Segmentation of Global Transplantation Market by Product Type 2014-2019
  • Exhibit 16: Segmentation of Global Transplantation Market by Geography 2014 and 2019
  • Exhibit 17: Transplantation Market in Americas 2014-2019 (US$ billion)
  • Exhibit 18: Transplantation Market in EMEA Region 2014-2019 (US$ billion)
  • Exhibit 19: Transplantation Market in APAC Region 2014-2019 (US$ billion)
  • Exhibit 20: Global Transplantation Market Segmentation by Geography 2014-2019 (US$ billion)
  • Exhibit 21: Global Transplantation Market Segmentation by Geography 2014-2019
  • Exhibit 22: Abbott Laboratories Inc.: Business Segmentation
  • Exhibit 23: Abbott Laboratories Inc.: Revenue by Business Segmentation 2012
  • Exhibit 24: Abbott Laboratories Inc.: Revenue by Business Segmentation 2011 and 2012 (US$ million)
  • Exhibit 25: Abbott Laboratories Inc.: Revenue by Geographical Segmentation 2012
  • Exhibit 26: Arthrex: Product Groups
  • Exhibit 27: Arthrex: Key Locations
  • Exhibit 28: Biomet: Product Segmentation by Revenue 2014
  • Exhibit 29: Biomet: Product Segmentation by Revenue 2013 and 2014 (US$ million)
  • Exhibit 30: Biomet: Geographical Segmentation by Revenue 2014
  • Exhibit 31: Kinetic Concepts: Business Segmentation 2013
  • Exhibit 32: Kinetic Concepts: Business Segmentation by Revenue 2013
  • Exhibit 33: Kinetic Concepts: Sales by Geography 2013
  • Exhibit 34: Medtronic: Business Segmentation by Revenue 2013
  • Exhibit 35: Medtronic: Business Segmentation by Revenue 2012 and 2013 (US$ million)
  • Exhibit 36: Medtronic: Geographical Segmentation by Revenue 2013
  • Exhibit 37: Novartis AG: Business Segmentation
  • Exhibit 38: Novartis AG: Revenue by Business Segmentation 2013
  • Exhibit 39: Novartis AG: Revenue by Business Segmentation 2012 and 2013 (US$ million)
  • Exhibit 40: Novartis AG: Revenue by Geographical Segmentation 2013
  • Exhibit 41: Stryker: Business Segmentation by Revenue 2013
  • Exhibit 42: Stryker: Business Segmentation by Revenue 2012 and 2013 (US$ million)
  • Exhibit 43: Stryker: Geographical Segmentation by Revenue 2013
Back to Top